These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients. Haq RU; Pendlebury WW; Fries TJ; Tandan R Muscle Nerve; 2003 Apr; 27(4):465-70. PubMed ID: 12661048 [TBL] [Abstract][Full Text] [Related]
27. Precipitating factors and patient outcomes in acute kidney injury treated with renal replacement therapy. McMillan M; Mactier R Scott Med J; 2011 Feb; 56(1):30-2. PubMed ID: 21515530 [TBL] [Abstract][Full Text] [Related]
28. Long-standing idiopathic hypoparathyroidism masking coexistent chronic inflammatory demyelinating polyneuropathy. França MC; de Castro R; de Oliveira MF; Garibaldi SG; Nucci A; de Souza Queiroz L; Kraemer MH J Peripher Nerv Syst; 2004 Dec; 9(4):196-7. PubMed ID: 15574130 [No Abstract] [Full Text] [Related]
29. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg. Caro XJ; Winter EF; Dumas AJ Rheumatology (Oxford); 2008 Feb; 47(2):208-11. PubMed ID: 18208823 [TBL] [Abstract][Full Text] [Related]
30. Inappropriate secretion of antidiuretic hormone in a patient with chronic inflammatory demyelinating polyneuropathy. Taguchi Y; Takashima S; Sasahara E; Kato Y; Orihara T; Inoue Y; Inoue H Intern Med; 2005 Jan; 44(1):65-7. PubMed ID: 15704666 [TBL] [Abstract][Full Text] [Related]
32. Intravenous immunoglobulin (IVIG) in the treatment of chronic demyelinating polyradiculoneuropathy. Van den Bergh PY Acta Neurol Belg; 2001 Sep; 101(3):147-51. PubMed ID: 11817262 [No Abstract] [Full Text] [Related]
33. [Remission of vitiligo during treatment with intravenous immunoglobulin: report of one case]. Badilla A; Díaz C Rev Med Chil; 2011 Apr; 139(4):484-8. PubMed ID: 21879188 [TBL] [Abstract][Full Text] [Related]
34. Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. Latov N; Deng C; Dalakas MC; Bril V; Donofrio P; Hanna K; Hartung HP; Hughes RA; Merkies IS; van Doorn PA; Arch Neurol; 2010 Jul; 67(7):802-7. PubMed ID: 20457948 [TBL] [Abstract][Full Text] [Related]
35. [Renal complications from intravenous immunoglobulins. Role of renal hemodynamic factors]. Poullin P; Moulin B; Ollier J; Benaicha M; Olmer M; Gabriel B Presse Med; 1995 Mar; 24(9):441-4. PubMed ID: 7746817 [TBL] [Abstract][Full Text] [Related]
36. Resolution of chronic inflammatory demyelinating polyneuropathy-associated central nervous system lesions after treatment with intravenous immunoglobulin. Fee DB; Fleming JO J Peripher Nerv Syst; 2003 Sep; 8(3):155-8. PubMed ID: 12904236 [TBL] [Abstract][Full Text] [Related]
37. Chronic inflammatory demyelinating polyradiculoneuropathy and severe peripheral oedema: a renal explanation. Henderson RD; Healy HG; McCombe PA; Lander CM J Clin Neurosci; 2000 Mar; 7(2):148-9. PubMed ID: 10844803 [TBL] [Abstract][Full Text] [Related]
39. Renal replacement therapy for prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials. Song K; Jiang S; Shi Y; Shen H; Shi X; Jing D Am J Nephrol; 2010; 32(5):497-504. PubMed ID: 20975263 [TBL] [Abstract][Full Text] [Related]
40. Acquired inflammatory demyelinating neuropathies. Ensrud ER; Krivickas LS Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]